PNT
POINT Biopharma Global Inc. Common Stock
Delisted
PNT was delisted on the 26th of December, 2023.
115 hedge funds and large institutions have $455M invested in POINT Biopharma Global Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 37 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
2% more capital invested
Capital invested by funds: $446M → $455M (+$9.47M)
8% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 37
Holders
115
Holding in Top 10
4
Calls
$66K
Puts
$1K
Top Buyers
| 1 | +$17M | |
| 2 | +$10.1M | |
| 3 | +$6.27M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$6.12M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$5.95M |
Top Sellers
| 1 | -$19.2M | |
| 2 | -$10.4M | |
| 3 | -$8.47M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$3.65M |
| 5 |
Millennium Management
New York
|
-$2.11M |